Suchergebnisse - "Lobbezoo, Dorien J. A."

PubPharm (6)

1

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer : a study of the SONABRE registry

enthalten in: Breast cancer research and treatment | 2022

von Meegdes, M. | Ibragimova, K. | Lobbezoo, D. | +16

2

Quality of life in a real-world cohort of advanced breast cancer patients : a study of the SONABRE Registry

enthalten in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | 2020

von Claessens, A. | Ramaekers, B. | Lobbezoo, D. | +7

3

Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients : A Study of the Southeast Netherlands Breast Cancer Consortium

enthalten in: The oncologist | 2015

von Seferina, S. | Lobbezoo, D. | de Boer, M. | +9

4

Combination of exemestane and everolimus may produce toxic side effects : a new treatment option for metastatic hormone-sensitive breast cancer

enthalten in: Nederlands tijdschrift voor geneeskunde | 2014

von Vincent, J. | de Boer, M. | Lobbezoo, D. | +2

5

Prognosis of metastatic breast cancer subtypes : the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

enthalten in: Breast cancer research and treatment | 2013

von Lobbezoo, D. | van Kampen, R. | Voogd, A. | +10

6

If there is no overall survival benefit in metastatic breast cancer : does it imply lack of efficacy? Taxanes as an example

enthalten in: Cancer treatment reviews | 2013

von Vriens, B. | Lobbezoo, D. | de Hoon, J. | +3

1
[1]